Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients

While kidney transplant recipients (KTRs) represent a high-risk population for severe SARS-CoV-2 infection, almost half of them do not develop adequate levels of antibodies conferring clinical protection despite 3 doses of the mRNA vaccine. In the present study we retrospectively analyzed the humora...

Descripción completa

Detalles Bibliográficos
Autores principales: Del Bello, Arnaud, Kamar, Nassim, Marion, Olivier, Izopet, Jacques, Abravanel, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502996/
https://www.ncbi.nlm.nih.gov/pubmed/36146517
http://dx.doi.org/10.3390/vaccines10091439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502996/
https://www.ncbi.nlm.nih.gov/pubmed/36146517
http://dx.doi.org/10.3390/vaccines10091439

Ejemplares similares